Product Information
DEXMETHYLPHENIDATE ER 10 MG CP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.4520 per EA under NDC 31722023001. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Dec 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722023001
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215523FDA Approved
12/8/2021
TE Code
AB
On Market Since
12/8/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 10 MG CP has been published 226 times since Jun 8, 2022, and over the history we have for it it has risen 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4520 per EA |
|---|---|
| All-time high | $1.7000 (Mar 11, 2026) |
| All-time low | $0.7112 (May 22, 2024) |
| 52-week high | $1.7000 |
| 52-week low | $1.3935 |
| Median price | $1.2797 |
| Average price | $1.2918 |
| Largest weekly change | +81.8% (Jun 19, 2024) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 10 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 10 MG CP, manufactured by Camber Pharmaceuticals Inc., is $1.4520 per EA (NDC 31722023001), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 10 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 10 MG CP has risen 13.9%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 10 MG CP?
Since Jun 8, 2022, the NADAC for DEXMETHYLPHENIDATE ER 10 MG CP has ranged from a low of $0.7112 (May 22, 2024) to a high of $1.7000 (Mar 11, 2026), with a median of $1.2797 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 10 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 10 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE ER 10 MG CP?
DEXMETHYLPHENIDATE ER 10 MG CP (NDC 31722023001) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.